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Abstract
Papillary thyroid carcinoma (PTC) is the most common type
of all thyroid carcinomas and accounts for up to 90% of all
thyroid malignancies. It is the most indolent form of the
disease and has an excellent prognosis. On the other hand,
Primary thyroid lymphoma (PTL) is a rare entity accounting
for only about 1% to 5% of all thyroid malignancies and
only 2% of extranodal lymphomas. Synchronous PTC and
PTL is a very rare condition and only a few cases have been
reported in the literature up till now. We report one such
case in a 52-year-old lady who was referred to us with
goiter and progressively increasing difficulty in breathing.




Primary thyroid lymphoma (PTL) is a rare entity which
accounts for only about 1% to 5% of all thyroid
malignancies and only up to 2% of extranodal
lymphomas.1,2 Clinical manifestation can vary but it is
usually characterised by painless thyroid mass, rapidly
enlarging in size and associated with compressive signs
and symptoms such as shortness of breath, stridor,
difficulty in swallowing and  hoarseness.3
In contrast, papillary thyroid carcinoma (PTC) is the most
common type of thyroid carcinoma and accounts for up to
70% to 90% of all thyroid cancers and is the most inert form
of the disease with an excellent prognosis, 20-year survival
rate being more than 90% when appropriately treated.4
Occurrence of simultaneous PTL and PTC is very rare and
only a few cases have been reported in the literature.3 Here,
we report a rare case of synchronous thyroid malignancy
of PTC and PTL and further discuss the management of this
case and sum up the characteristics of these diseases based
on the available literature.
Case Report
A 52-year-old female patient was referred to the ENT clinic
of Aga Khan University Hospital, Karachi in April, 2019 with
complaint of gradually progressive painless neck swelling
for the last one year associated with difficulty in breathing
for the past three months. There was no history of change
in voice, dysphagia or weight loss. The patient had no
family history of thyroid diseases, immunodeficiency or
prior malignancy or radiation to the neck.
On physical examination, her thyroid gland was grossly
enlarged, measuring approximately 8 x 6 cm in size and the
left lobe was larger than the right one. Swelling was firm,
non-tender and moving while swallowing. Multiple cervical
lymph nodes were palpable at left level II to V. No
significant findings were noted on systemic examination.
Laboratory work up was performed which showed normal
thyroid profile. Ultrasound of the neck showed
heterogeneously enlarged thyroid gland with left- sided
cervical lymphadenopathy. Contrast enhanced computed
tomography (CT) scan showed enhancement of the left
thyroid lobe with compression of the trachea, along with
multiple enlarged lymph nodes at the left level II to V and
in the central cervical compartment. Level III and IV nodes
were compressing the left internal jugular vein (IJV). As
ultrasound had revealed a left thyroid heterogenous lobe,
ultrasound-guided Fine Needle Aspiration Biopsy (FNAB)
was done from the left lobe. The smear revealed scattered
lymphocytes, a few macrophages and plasma cells against
haemorrhagic background with scanty colloid. Clusters and
groups of Hurthle cells and a few clusters of follicular cells
were also present. The cytologist was of the opinion that
there was a possibility of Hashimoto’s thyroiditis. As the
patient complained of compressive symptoms and
progressive difficulty in breathing, she underwent total
thyroidectomy with central and left level II to V neck
dissection.
Intraoperatively the thyroid gland was enlarged with the
left lobe measuring 6x5cm and the right lobe measuring
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3x4 cm. Thyroid gland was adherent to overlying strap
muscles, and left level II to V lymph nodes were enlarged,
firm to hard and adherent to the left internal jugular vein.
Bilateral recurrent laryngeal nerves and right superior and
inferior parathyroid glands were identified and preserved.
On the first post-operative day, the patient had a neck drain
output of 800ml in 24 hours. Chyle leak was suspected and,
therefore, Somatostatin 10mg subcutaneously was given
every eight hourly, fat-free diet was started and bolster
dressing over left neck was applied. On the next two days
the drain output increased to 1,320 ml and 1,980 ml,
respectively. The patient was kept NPO and fluid
replacement with electrolyte monitoring was done.
Despite all the measures the neck drain output continued
to be more than 1,000 ml for the following two days.
The patient underwent re-exploration of the neck and the
Chyle leak was repaired. Intra-operatively Chyle leak was
identified at level IV, and multiple under-running sutures
were taken to stop the leak. Valsalva was given and no leak
was identified intraoperatively after the repair. Post-
operatively she remained stable, the drain output was less
than 30 ml on the next two days and she was discharged
after the removal of the drain.
Her final histopathology showed follicular variant of
papillary thyroid carcinoma in the right lobe (Figure 1).
Pathological staging was pT1aN0. The left thyroid lobe
showed high grade B-cell lymphoma. Lymphoma was
positive for immunohistochemical markers including LCA,
CD20, CD10, BCL-6 and Ki-67 (70% to 80%). Cyclin D1 was
negative. Features favoured Diffuse Large B-cell
Lymphoma. Two out of the 22 lymph nodes (left level II-VI)
were involved by high grade B-cell lymphoma (Figure 2).
The diagnosis of lymphoma was established only after the
histopathological analysis of the thyroid gland after the
surgery; therefore, the oncologist was consulted after the
histopathology report and the patient was treated
accordingly.
She was referred to the medical oncologist for
chemotherapy and was given six cycles of R-CHOP
regimen. She was also referred to the endocrinologist and
nuclear medicine for thyroxine replacement. Radioactive
iodine ablation (RAI) was not given as the pathological
staging of PTC was pT1a N0. She is on regular follow-ups
and after a year of completion of the treatment she is
disease free.
Discussion
In a retrospective survey done by Demandante et al on
1,104,269 patients with tumour, the incidence of multiple
primary cancers was reported from 0.73% to 11.7%, mostly
prevalent in the elderly population.5 Warren and Gates in
1932, coined the term multiple primary cancers.6
Simultaneous or sequential occurrence of two or more
primary cancers in the same patient is termed as multiple
primary cancers.7 The coexistence of PTC and lymphoma is
extremely uncommon. Only a handful of cases have been
reported in the literature with simultaneous lymphoma
and PTC.8-13 The current patient also had simultaneous
malignancies with different characteristics and features on
histopathological examinations and her condition was
consistent with the definition of multiple primary cancers.
Up to 20% to 50% of the patients with PTC have cervical
metastasis at the time of diagnosis. The most common site
for regional metastasis is central level VI and rarely in lateral
neck and anterior mediastinum.14 Similarly, neck nodal
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Figure-1: Microscopic slide with Papillary thyroid carcinoma showing mitosis. The
lesional cells show nuclear enlargement with overlapping and chromatin
clearing. Nuclear grooving is also noted. The centre field shows a mitotic
figure as well (arrow).
Figure-2: Microscopic slide showing high magnified view of Lymphoma. The area
bordered by black line shows residual thyroid follicles which are being
infiltrated by atypical lymphoid cells, which are also seen in the rest of 
the image.
involvement is also a common presentation in cases of
lymphoma.15 In our patient, there were multiple enlarged
cervical lymph nodes on the left side, fused together with
each other. FNAC of the lymph node should have also been
performed to confirm metastasis from PTC or any other
lesion. Similarly, in patients with Hodgkin’s lymphoma (HL)
and a suspicious thyroid nodule, a FNAC of that nodule
should be performed to confirm the diagnosis and exclude
thyroid malignancy.4
Due to lack of a standard approach for synchronous
multiple primary malignancies, it is always very difficult to
manage such cases. Surgery is the mainstay of treatment
for thyroid cancers followed by radioactive iodine (RAI)
therapy after the surgery to improve the outcomes by
looking after the residual or persistent disease in patients
with differentiated thyroid cancer,14 whereas in cases of HL,
chemotherapy and radiotherapy are the frontline
treatment options16 and with the recent advancements in
the treatment protocols, 90% of the patients with HL
achieve an excellent control of the diseases.15
When a patient is diagnosed with synchronous PTC and
lymphoma, starting the treatment of lymphoma will be the
optimal option, given the fact that PTC is the most idle form
of thyroid cancer17 and enlarged cervical
lymphadenopathy secondary to lymphoma will disappear
or regress after the treatment of lymphoma, thus making
surgery for PTC much easier with decreased chances of
complications and incomplete surgery.4 In this case,
cervical lymph nodes dissection could have been avoided
as these nodes would have responded to
chemoradiotherapy and, hence, we agree to the
“Lymphoma first approach” recommended for the
synchronised condition.4,9
Our patient developed Chyle leakage post-operatively
which is the surgical complication of extensive neck
dissection.18 Although we were able to manage this
complication, it should be kept in mind that if the
“Lymphoma first approach” was opted for this patient,
lateral neck dissection and its possible complication could
have been avoided. Therefore, we suggest that in cases of
synchronous PTC and HL, initial treatment plan should be
chemoradiotherapy followed by total thyroidectomy and
RAI therapy.
Conclusion
Synchronous PTC and lymphoma is an extremely rare
condition which poses a significant management
challenge. Lymphoma first approach should be opted for
in such cases, followed by total thyroidectomy and RAI
therapy for thyroid malignancy to achieve optimal long-
term survival. Studies with larger sample size are required
to further clarify this condition.
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